A new therapeutic approach for type 1 diabetes: Rationale for GNbAC1, an anti ‐HERV‐W‐Env monoclonal antibody

Diabetes, Obesity and Metabolism, EarlyView.

https://onlinelibrary.wiley.com/doi/abs/10.1111/dom.13357?af=R

Source: Diabetes, Obesity and Metabolism - June 11, 2018 Category: Endocrinology Authors: Francois Curtin MD , Corinne Bernard PhD , Sandrine Levet PhD , Herv é Perron PhD , Hervé Porchet MD , Julie Médina PhD , Sam Malpass MSc , David Lloyd PhD , Richard Simpson DM , Source Type: research

More News: Diabetes | Diabetes Type 1 | Eating Disorders & Weight Management | Endocrinology | Obesity